3rd Quarter - Report
WINNING STRATEGIES WASHINGTON for DBV TECHNOLOGIES
Client
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Innovation in medical therapies to treat childhood food allergies
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH CONNOLLY | Assistant Director of the Office of Public Health, Office of National Drug Control Policy |
| MICHAEL A MEROLA | Deputy CoS, Sen. Torricelli |
| DONNA MULLINS | CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.